Thomas Stangler Sandoz
Thomas Stangler Sandoz Regulatory CMC Director
Thomas is a Regulatory CMC Director at Sandoz with 15 years of experience in developing Biosimilars for Sandoz and innovative medicines for Novartis. He holds an M.Sc. in physics and a PhD in biochemistry. He is interested in enhanced/QbD approaches to the development of Biologics and the implementation of the corresponding ICH guidances. After ICH Q8, Q9, and Q11, ICH Q12 is for him the next logical step in ensuring product quality throughout the pharmaceutical lifecycle.